High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system

Katherine H. Kim, Charlotte Dodsworth, Andrea Paras, Barbara K. Burton*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology